Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

This study has been completed.
Information provided by:
Novo Nordisk A/S Identifier:
First received: December 5, 2011
Last updated: August 30, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)